Author:
Ding Haoran,Liu Feng,Wang Mengyue,Dong Bangjian,Li Xiaobo
Funder
National Key Research and Development Program of China
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference33 articles.
1. P.R.C.N.H Commission, Guideline on diagnosis and treatment of COVID-19 (Trial 6th edition).〈http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf〉, 2020 (accessed 18 Feb.2020).
2. Traditional Chinese medicine for COVID-19 treatment;Ren;Pharmacol. Res.,2020
3. Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19);Huang;Pharmacol. Res.,2020
4. Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming;Chen;Biomed. Pharmacother.,2020
5. Inhibition of drug-metabolizing enzymes by Qingfei Paidu decoction: Implication of herb-drug interactions in COVID-19 pharmacotherapy;Zhang;Food Chem. Toxicol.,2021
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献